| Literature DB >> 35840875 |
Frederick Sieber1, Susan Gearhart2, Dianne Bettick3, Nae-Yuh Wang4.
Abstract
BACKGROUND: Frailty has been associated with postoperative delirium (POD). Studies suggest that the Fried phenotype has a stronger association with POD than the Edmonton Frailty Scale (EFS) criteria. Although phenotypic frailty is recognized as a good predictor of delirium, the EFS has higher ratings for feasibility in the surgical setting. Thus, our aim was to determine the association between EFS-assessed vulnerability and POD in an elective surgical population of older adults. A secondary aim was to determine which domains assessed by the EFS were closely associated with POD.Entities:
Keywords: Complications; Delirium; Elective surgical procedures; Frailty; Postoperative
Mesh:
Year: 2022 PMID: 35840875 PMCID: PMC9288043 DOI: 10.1186/s12877-022-03252-8
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 4.070
Fig. 1Flow diagram for selection of final electronic medical records for data analysis
Univariate analysis of 4AT score risk factors and correlates among 324 older patients
| Parameter | 4AT < 4 | 4AT ≥ 4 | |
|---|---|---|---|
| Total, n (%) | 309 (95.4) | 15 (4.6) | |
| Demographics | |||
| Sex, n (%) | 0.79 | ||
| Female | 123 (96.1) | 5 (3.9) | |
| Male | 186 (94.9) | 10 (5.1) | |
| Race, n (%) | 0.43 | ||
| Caucasian | 238 (95.8) | 10 (4.2) | |
| Black | 61 (92.4) | 5 (7.6) | |
| Other | 20 (100.0) | 0 (0.0) | |
| Age, y | |||
| Mean (SD) | 73.1 (6.2) | 77.5 (6.3) | 0.007 |
| Median (IQR) | 72.0 (68.0–77.0) | 79.0 (71.0–82.0) | 0.17 |
| Surgical characteristics and comorbidities | |||
| ASA status, n (%) | 0.02 | ||
| 2 | 92 (97.9) | 2 (2.1) | |
| 3 | 197 (95.2) | 9 (4.4) | |
| 4 | 20 (87.0) | 4 (16.7) | |
| Total anesthesia time, min | |||
| Mean (SD) | 237.7 (117.7) | 241.8 (147.8) | 0.90 |
| Median (IQR) | 207.0 (160.0–207.0) | 209 (83.0–373.0) | 0.79 |
| Total units RBC infused | |||
| Mean (SD) | 0.1 (0.5) | 0.3 (0.6) | 0.12 |
| Median (IQR) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0003 |
| Elixhauser 30-day readmission score | |||
| Mean (SD) | 21.7 (23.5) | 58.3 (43.4) | 0.0056 |
| Median (IQR) | 15.0 (5.0–29.0) | 55.0 (17.0–92.0) | 0.003 |
| Elixhauser mortality score | |||
| Mean (SD) | 4.4 (10.2) | 13.9 (18.9) | 0.001 |
| Median (IQR) | 3.0 (−1.0–8.0) | 10.0 (1.0–30.0) | 0.06 |
| EFS total score ≥ 6, n (%) | 0.0007 | ||
| No | 236 (97.9) | 5 (2.1) | |
| Yes | 73 (88.0) | 10 (12.1) | |
| Anesthesia type, n (%) | 0.07 | ||
| Regional | 23 (95.8) | 1 (4.2) | |
| MAC | 13 (81.3) | 3 (18.8) | |
| Spinal/epidural | 26 (100.0) | 0 (0.0) | |
| General | 247 (95.7) | 11 (4.3) | |
| Surgical service area, n (%) | 0.09 | ||
| General | 141 (97.9) | 3 (2.1) | |
| Neurosurgery | 12 (92.3) | 1 (7.7) | |
| Orthopedics | 30 (100.0) | 0 (0.0) | |
| Urology | 35 (92.1) | 3 (7.9) | |
| Vascular | 80 (92.0) | 7 (8.1) | |
| Othera | 11 (91.7) | 1 (8.3) | |
| Characteristics at or after hospital discharge | |||
| Length of stay, days | |||
| Mean (SD) | 3.9 (4.4) | 8.0 (10.8) | 0.0015 |
| Median (IQR) | 2.3 (1.3–4.4) | 3.9 (1.4–9.2) | 0.79 |
| Discharge disposition, n (%) | < 0.0001 | ||
| Expired | 0 (0.0) | 3 (100.0) | |
| Home- / self- / home-health-care | 264 (98.1) | 5 (1.9) | |
| Skilled nursing facility | 40 (87.0) | 6 (13.0) | |
| Rehab/other | 5 (83.3) | 1 (16.7) | |
| 30-Day mortality, n (%) | 0.0003 | ||
| No | 308 (96.3) | 12 (3.8) | |
| Yes | 1 (25.0) | 3 (75.0) | |
ASA American Society of Anesthesiologists, EFS Edmonton Frailty Scale, IQR Interquartile range, MAC Monitored anesthesia care, RBC Red blood cells, SD standard deviation
aOther includes gynecologic, otolaryngologic, and plastic and reconstructive surgeries
Adjusted odds ratios of postoperative 4AT score ≥ 4 associated with selected preoperative risk factors
| Models and variables | Odds ratio | 95% Confidence limits | ||
|---|---|---|---|---|
| Model 1 | ||||
| EFS score ≥ 6, yes vs no | 4.86 | 1.62 | 14.58 | 0.005 |
| Age, per 5-year increase | 1.37 | 1.14 | 1.54 | 0.09 |
| Model 2 | ||||
| EFS score ≥ 6, yes vs no | 5.25 | 1.74 | 15.88 | 0.003 |
| ASA | 0.08a | |||
| 2 vs 4 | 0.24 | 0.04 | 1.35 | 0.10 |
| 3 vs 4 | 0.24 | 0.07 | 0.87 | 0.03 |
| Model 3 | ||||
| EFS score ≥ 6, yes vs no | 3.86 | 1.26 | 11.80 | 0.018 |
| Elixhauser 30-day readmission score, per 10-point increase | 1.32 | 1.14 | 1.53 | 0.0002 |
| EFS score ≥ 6, yes vs no | 3.49 | 1.06 | 11.54 | 0.04 |
| Age, per 5-year increase | 1.41 | 0.95 | 2.09 | 0.09 |
| ASA | 0.33a | |||
| 2 vs 4 | 0.67 | 0.09 | 5.22 | 0.70 |
| 3 vs 4 | 0.35 | 0.08 | 1.59 | 0.17 |
| Elixhauser 30-day readmission score, per 10-point increase | 1.27 | 1.07 | 1.50 | 0.007 |
ASA American Society of Anesthesiologists, EFS Edmonton Frailty Scale
aType 3 Wald’s chi-square test
Odds ratios of specific Edmonton Frailty Scale domains for postoperative 4AT score ≥ 4
| Edmonton Frailty Scale domain | Odds ratio [95% CI]a | |
|---|---|---|
| Clock draw | 0.44b | |
| Spacing errors vs no error | 1.27 [0.32–5.00] | 0.73 |
| Other errors vs no error | 2.62 [0.60–11.42] | 0.20 |
| Hospital admissions | 0.15b | |
| 1–2 vs 0 | 3.02 [0.80–11.33] | 0.10 |
| ≥ 2 vs 0 | 3.83 [0.87–16.83] | 0.08 |
| General health | 0.44b | |
| Fair vs good to excellent | 0.68 [0.19–2.48] | 0.56 |
| Poor vs good to excellent | 1.86 [0.41–8.43] | 0.42 |
| Functional independence (ADL needs) | 0.07b | |
| 2–4 vs 0–1 | 3.37 [1.04–10.98] | 0.04 |
| 5–8 vs 0–1 | 5.02 [0.84–30.13] | 0.08 |
| Social support | 0.84b | |
| Sometimes vs always | 0.72 [0.04–12.80] | 0.82 |
| Never vs always | 2.63 [0.08–91.68] | 0.59 |
| Polypharmacy, yes vs no | 0.80 [0.21–3.11] | 0.75 |
| Forgetting to take medications, yes vs no | 2.89 [0.94–8.82] | 0.06 |
| Weight loss, yes vs no | 1.43 [0.45–4.55] | 0.54 |
| Depressed mood, yes vs no | 1.27 [0.37–4.31] | 0.70 |
| Incontinence, yes vs no | 3.77 [1.19–11.92] | 0.02 |
| Functional performance (timed get up and go) | 0.10b | |
| 11–20 sec vs 0–10 sec | 3.58 [0.98–13.15] | 0.05 |
| > 20 sec / unwilling / needs assistance vs 0–10 sec | 3.84 [0.95–15.55] | 0.06 |
ADL Activities of daily living
aEstimates from separate logistic regression analysis models adjusted for age, ASA status, and Elixhauser comorbidity score for 30-day readmission
bType 3 Wald’s chi-square test